Dolutegravir and rifampicin interaction - real-life virologic outcomes of Namibians with HIV and tuberculosis
{{output}}
Dolutegravir and rifampicin are often used together when treating patients coinfected with HIV and tuberculosis. Guidelines recommend increasing the dose of dolutegravir to 50 mg twice daily when administered with rifampicin due to strong CYP450 enzyme inducti... ...
